Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds SAQsendocrinology-diabetes-and-growth

Paeds SAQs · endocrinology-diabetes-and-growth

Type 1 diabetes: insulin therapy, technology and ambulatory care — formative SAQs

Two formative SAQs on the ongoing care of established type 1 diabetes: a nine-year-old who develops ketoacidosis after insulin is omitted during a viral illness, testing sick-day management and the never-stop-insulin principle; and a seven-year-old on a pump with abdominal pain and ketones, testing the pump-cannula pitfall; plus the HbA1c and time-in-range targets and the transition plan.

20 marks30 min3 min readVerification in progress

Target exams

RACP General PaediatricsRACP DWEMRCPCH TheoryABP General Pediatrics
On this page
Study tools

Target exams

RACP General PaediatricsRACP DWEMRCPCH TheoryABP General Pediatrics
Prompt
Type 1 diabetes: insulin therapy, technology and ambulatory care

SAQ 1 — The sick child whose insulin was stopped (10 marks)

A 9-year-old with established type 1 diabetes on a basal-bolus regimen develops a febrile viral illness with poor appetite. The parents, concerned that she is eating little, omit her insulin for 24 hours. She now presents with vomiting, deep sighing respirations and drowsiness; glucose is 24 mmol/L, blood ketones 4.2 mmol/L, and venous pH 7.12. This is presentation diabetic ketoacidosis precipitated by the most common sick-day error. [2]

Answer the following

  1. Identify the critical error in the sick-day management that precipitated the deterioration, and state the governing principle of sick-day insulin management. [2]
  2. Outline the correct sick-day routine the family should have followed at home. [2]
  3. List the escalation criteria that should have prompted urgent review before ketoacidosis developed. [2]
  4. State two specific education points you would reinforce with this family before discharge to prevent recurrence. [1]

Model marking guide

  1. The critical error was stopping insulin during illness. The governing principle is that insulin is never stopped during intercurrent illness — fever and the stress response raise insulin needs, so the dose is usually increased, and withholding insulin is the commonest precipitant of sick-day ketoacidosis. [2]
  2. Check glucose every 2–4 hours; check blood ketones (beta-hydroxybutyrate) at every glucose check; maintain hydration with small frequent carbohydrate-containing fluids; give extra rapid-acting insulin for hyperglycaemia with ketones per the sick-day plan; never omit basal insulin. [2]
  3. Escalate for: vomiting preventing fluid retention; ketones rising despite extra insulin (above 1.5 mmol/L and climbing); deep or rapid breathing; drowsiness; persistent hyperglycaemia above 15–20 mmol/L. [2]
  4. Reinforce that insulin is never stopped during illness and the dose usually rises; ensure a written sick-day plan with a named team contact and clear thresholds for calling; confirm ketone strips and sick-day supplies at home; teach the family to call early in the ketotic-but-not-acidotic window. [1]
Paediatrics Fellowship Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References4ShowHide
  1. [1]Cengiz E; Danne T; et al ISPAD Clinical Practice Consensus Guidelines 2024: Insulin and adjunctive treatments in children and adolescents with diabetes. Horm Res Paediatr, 2024.PMID 39884261
  2. [2]Phelan H; Hanas R; et al Sick day management in children and adolescents with diabetes. Pediatr Diabetes, 2022.PMID 36093857
  3. [3]de Bock M; Agwu JC; et al ISPAD Clinical Practice Consensus Guidelines 2024: Glycemic targets. Horm Res Paediatr, 2024.PMID 39701064
  4. [4]Biester T; Berget C; et al ISPAD Clinical Practice Consensus Guidelines 2024: Diabetes technologies — insulin delivery. Horm Res Paediatr, 2024.PMID 39657603
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousType 1 diabetes: diagnosis and initial management — formative SAQsendocrinology-diabetes-and-growthNextType 2 diabetes and metabolic syndrome in youth — formative SAQsendocrinology-diabetes-and-growth